PolyNovo Limited
ASX:PNV.AX
2.56 (AUD) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PolyNovo Limited |
Symbool | PNV.AX |
Munteenheid | AUD |
Prijs | 2.56 |
Beurswaarde | 1,768,171,520 |
Dividendpercentage | 0% |
52-weken bereik | 1.095 - 2.78 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Swami Raote BPHARM, M.B.A. |
Website | https://polynovo.com |
An error occurred while fetching data.
Over PolyNovo Limited
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)